Keywords: Alzheimer's Disease, Alzheimer's Disease
Motivation: Glymphatic clearance of toxic proteins, quantified by the “DTI-along-the-perivascular-space” (ALPS) index, is impaired in Alzheimer’s disease (AD)
Goal(s): We tested the association of the ALPS index to CSF Aβ and tau.
Approach: We used imaging, CSF biomarker, and neuropsychological assessment data from 12 MCI, 21 AD, and 11 other dementia patients. We generated color FA maps and ALPS ROIs, before testing the interaction effects of ALPS × group on each CSF biomarker measure.
Results: In our sample of AD and mild cognitive impairment patients (n=44), we found significant positive association of CSF tau and phosphorylated tau (but not amyloid-β) with the ALPS index.
Impact: Our study establishes a novel link between brain glymphatic function and CSF phosphorylated tau in AD via the ALPS index.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords